This work provides new insight into the age-related basis of Alzheimer's disease (AD), the composition of intraneuronal amyloid (iA), and the mechanism of an age-related increase in iA in adult AD-model mouse neurons. A new end-specific antibody for A 45 and another for aggregated forms of A provide new insight into the composition of iA and the mechanism of accumulation in old adult neurons from the 3xTg-AD model mouse. iA levels containing aggregates of A 45 increased 30-50-fold in neurons from young to old age and were further stimulated upon glutamate treatment. iA was 8 times more abundant in 3xTg-AD than non-transgenic neurons with imaged particle sizes following the same log-log distribution, suggesting a similar snow-ball mechanism of intracellular biogenesis. Pathologically misfolded and mislocalized Alz50 tau colocalized with iA and rapidly increased following a brief metabolic stress with glutamate. APP-CTF, A 45 , and aggregated A colocalized most strongly with mitochondria and endosomes and less with lysosomes and autophagosomes. Differences in iA by sex were minor. These results suggest that incomplete carboxyl-terminal trimming of long As by gamma-secretase produced large intracellular deposits which limited completion of autophagy in aged neurons. Understanding the mechanism of age-related changes in iA processing may lead to application of countermeasures to prolong dementia-free health span. human clinical trials [4]. Although gamma-secretase inhibitors were screened on the basis of their inhibition of the secretion of A, a detailed analysis of the mechanism indicated that Semagacestat slows the tripeptide carboxypeptidase terminal triming of the primary products of gamma-secretase endoproteolysis leading to the accumulation of "long As" ending at residues 45, 46, 48, and 49 of the A sequence (Fig. 1), similar to many of the FAD mutations in presenilin, which interfere with the processivity of the tripeptidase trimming [5][6][7]. These results suggest that the reason that Semagacestat and Avagacestat [8] caused cognitive worsening is the same reason that FAD mutations in presenilins cause early onset